++
For further information, see CMDT Part 39-10 Gastric Adenocarcinoma
+++
Essentials of Diagnosis
++
Dyspeptic symptoms with weight loss in patients age > 40
Iron deficiency anemia; occult blood in stools
Abnormality on upper gastrointestinal series or endoscopy
+++
General Considerations
++
There are two main histologic variants of gastric cancer
Intestinal-type gastric cancer resembles intestinal cancers in forming glandular structures
Accounts for 70–80% of cases
Occurs twice as often in men as women
Primarily affects older people (mean age 63 years)
More strongly associated with environmental factors
Diffuse gastric cancer is poorly differentiated, has signet-ring cells, and lacks formation of glandular structures
Accounts for 20–30% of cases
Affects men and women equally
Occurs more commonly in young people
Not as strongly related to Helicobacter pylori infection
Has a worse prognosis than the intestinal type
Most diffuse gastric cancers are attributable to acquired or hereditary mutations in the genes regulating the E-cadherin cell adhesion protein
In addition to the hereditary diffuse gastric cancer, there are other hereditary cancer predisposition syndromes that account for 3–5% of gastric cancers
Most gastric cancers arise in the body and antrum
Chronic H pylori gastritis is the major risk factor
Other risk factors for intestinal-type gastric cancer
++
Gastric adenocarcinoma is the most common cancer worldwide
Incidence in the United States has declined rapidly over last 70 years
In the United States, there were an estimated 27,600 new cases and 11,010 deaths in 2020
Incidence is higher in Asian Americans, Hispanics, African Americans and American Indian/Alaska Natives
++
Generally asymptomatic or nonspecific symptoms until advanced disease
Dyspepsia, vague epigastric pain, anorexia, early satiety, and weight loss
Acute upper gastrointestinal bleeding with hematemesis or melena
Postprandial vomiting suggests pyloric obstruction
Progressive dysphagia suggests lower esophageal obstruction
Physical examination rarely helpful
Gastric mass is palpated in < 20%
Signs of metastatic spread include
Left supraclavicular lymph node (Virchow node)
Umbilical nodule (Sister Mary Joseph nodule)
Rigid rectal shelf (Blumer shelf)
Ovarian metastases (Krukenberg tumors)
+++
Differential Diagnosis
++
Benign gastric ulcers
Lymphoma
Ménétrier disease
++
Iron deficiency anemia or anemia of chronic disease
Liver biochemical test abnormalities, particularly elevation of alkaline phosphatase, if there is metastasis to liver
Tumor markers
Do not have established clinical validity in screening, diagnosis, or management of gastric cancer
However, can assist in monitoring treatment response when checked serially
++